SCHEMBL13228486

SCHEMBL13228486

Cc1cc2c(c(C)c1CF)N(CC1CC1)CCC[C@@H]2N(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1nnn(CCN)n1

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CETP P11597 20/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2481299 0.91 CETP (0.60) CETP
SCHEMBL2481300 0.91 CETP (0.60) CETP
SCHEMBL1380460 0.85 CETP (0.55) CETP
SCHEMBL1380458 0.85 CETP (0.55) CETP
Hydrochloric Acid SCHEMBL1380060 0.85 CETP (0.54) CETP
Hydrochloric Acid SCHEMBL1380057 0.85 CETP (0.54) CETP
SCHEMBL13227956 0.84 CETP (0.51) CETP
SCHEMBL13229278 0.84 CETP (0.66) CETP
SCHEMBL2479547 0.82 CETP (0.72) CETP
SCHEMBL2479545 0.82 CETP (0.72) CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7786108-B2 Compounds and method for treating dyslipidemia ELI LILLY AND COMPANY (US) 2010-08-31 US disclosed